News Focus
News Focus
Followers 3
Posts 219
Boards Moderated 0
Alias Born 08/05/2015

Re: Joe Kaplan post# 43656

Friday, 01/07/2022 7:05:58 PM

Friday, January 07, 2022 7:05:58 PM

Post# of 44697
I’m still in both Joe and I’m of the opinion that whatever unfolds between Relief and NRXP NeuroRX won’t get less of a slice of pie than what they initially agreed upon. I believe both companies will rise but Relief has more things going for it in the coming months and years. An approval for Aviptadil will be a grand slam for both companies .
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y